[{"PropertyPlantAndEquipmentNet_0_Q1_USD":1417900000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":8100000.0,"AssetsCurrent_0_Q1_USD":3069200000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":772500000.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":-500000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":1800000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-49700000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_0_Q1_USD":155500000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q1_USD":3900000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":135000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-172400000.0,"DerivativeLiabilitiesCurrent_0_Q1_USD":16100000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":482900000.0,"RestrictedCashCurrent_0_Q1_USD":16400000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":195800000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_0_Q1_USD":189500000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":296100000.0,"OtherNoncashIncomeExpense_1_Q1_USD":2700000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":330800000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":921000000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":152800000.0,"CommonStockSharesIssued_0_Q1_shares":637500000.0,"EquitySecuritiesFvNi_0_Q1_USD":30500000.0,"OtherReceivables_0_Q1_USD":77700000.0,"UnrecognizedTaxBenefits_0_Q1_USD":300500000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":86800000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_0_Q1_USD":191300000.0,"TreasuryStockValue_0_Q1_USD":2206700000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":31600000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_1_Q1_USD":1000000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q1_USD":24300000.0,"TreasuryStockShares_0_Q1_shares":15700000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":293400000.0,"ProceedsFromIssuanceOfLongTermDebt_1_Q1_USD":4500000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":77400000.0,"Assets_0_Q1_USD":7213700000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"EquityMethodInvestments_0_Q1_USD":7100000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-9300000.0,"IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1_Q1_USD":11500000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":637500000.0,"RepaymentsOfLongTermDebtAndCapitalSecurities_1_Q1_USD":4900000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":51100000.0,"AccountsReceivableNetCurrent_0_Q1_USD":586600000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":5500000.0,"ProceedsFromStockPlans_1_Q1_USD":31600000.0,"PrepaidExpenseCurrent_0_Q1_USD":77300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":631300000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":14200000.0,"EarningsPerShareBasic_1_Q1_USD":0.54,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":1800000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":207000000.0,"AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_0_Q1_USD":569700000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":23200000.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":302600000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q1_USD":4500000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-4800000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1496800000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":67100000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1174200000.0,"OtherAssetsNoncurrent_0_Q1_USD":125500000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":326900000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":338200000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-2500000.0,"OtherAssetsCurrent_0_Q1_USD":229100000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":-4500000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":1800000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q1_USD":156400000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-274300000.0,"LiabilityForUncertainTaxPositionsNoncurrent_0_Q1_USD":224200000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.131,"DepreciationDepletionAndAmortization_1_Q1_USD":32400000.0,"ShareBasedCompensation_1_Q1_USD":28200000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":88500000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":623200000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":132200000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":300500000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-32200000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":28200000.0,"InterestIncomeExpenseNet_1_Q1_USD":300000.0,"Goodwill_0_Q1_USD":1170800000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":8100000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-11300000.0,"RestrictedCashNoncurrent_0_Q1_USD":300000.0,"EarningsPerShareDiluted_1_Q1_USD":0.54,"CommonStockSharesOutstanding_0_Q1_shares":621800000.0,"ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_1_Q1_USD":50000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-9300000.0,"CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_1_Q1_USD":-9000000.0,"TaxesPayableCurrentAndNoncurrent_0_Q1_USD":215300000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":4903200000.0,"LiabilitiesCurrent_0_Q1_USD":799000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":1190900000.0,"AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_0_Q1_USD":573300000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-2900000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":181600000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":36400000.0,"OperatingLeasePayments_1_Q1_USD":7700000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":296100000.0,"RestructuringReserveCurrent_0_Q1_USD":14800000.0,"NoncurrentAssets_0_Q1_USD":1630700000.0,"IncreaseDecreaseInDeferredIncomeTaxes_1_Q1_USD":-10800000.0,"InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0_Q1_USD":37600000.0,"GrossProfit_1_Q1_USD":923200000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":330300000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":10700000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":87000000.0,"LongTermDebtNoncurrent_0_Q1_USD":595200000.0,"AccountsPayableCurrent_0_Q1_USD":150400000.0,"LitigationReserveNoncurrent_0_Q1_USD":222100000.0,"LongTermInvestments_0_Q1_USD":802200000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":914700000.0,"InventoryNet_0_Q1_USD":767900000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":14100000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":24500000.0,"OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_0_Q1_USD":123000000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":302600000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":389300000.0,"OperatingIncomeLoss_1_Q1_USD":383500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1216600000.0,"CommonStockSharesAuthorized_0_Q1_shares":1050000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":5400000.0,"LitigationSettlementExpense_1_Q1_USD":6400000.0,"IncreaseDecreaseInAccountsAndOtherReceivables_1_Q1_USD":89500000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1_Q1_USD":-900000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":1.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":209300000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q1_USD":181600000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q1_USD":-300000.0,"PaymentsToAcquireHeldToMaturitySecurities_1_Q1_USD":0.0,"PreferredStockValue_0_Q1_USD":0.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":8500000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":106000000.0,"IncomeTaxExaminationEstimateOfPossibleLoss_1_Q1_USD":200000000.0,"LitigationReserveCurrent_0_Q1_USD":50000000.0,"AccruedMarketingCostsCurrent_0_Q1_USD":15900000.0,"StockholdersEquity_0_Q1_USD":4658400000.0,"DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_0_Q1_USD":104700000.0,"ShortTermInvestments_0_Q1_USD":156400000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":250800000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":26500000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q1_USD":0.0,"IncreaseDecreaseInNotesReceivables_1_Q1_USD":3600000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":28200000.0,"PreferredStockSharesAuthorized_0_Q1_shares":50000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":197500000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":7213700000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":3500000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":6700000.0,"Ticker":"EW","CIK":"1099800","name":"EDWARDS LIFESCIENCES CORP","OfficialName":"Edwards Lifesciences Corporation Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77366347639.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"SP500","filed":"20210428"}]